NASDAQ:EDIT   Editas Medicine, Inc.
EDIT - Solid growth stock within the biotech industry recently beat down, currently off 62% from the highs. This one loves holding Fibs so if we see someone support at this 38 that would be a solid entry. Cathie also buying dips on this one, and with the market showing signs of strength, Huge R/R on this as Growth comes back - the company is a disruptor in the industry!
Entry at 37-39, PT 48.8, 54.7, SL under 37

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.